Temporal and geographic variation in the systemic treatment of advanced prostate cancer

Por Caram, Megan E. V., Estes, Jason P., Griggs, Jennifer J., Lin, Paul, Mukherjee, Bhramar
Publicado no BMC Cancer (2018)

Early National Dissemination of Abiraterone and Enzalutamide for Advanced Prostate Cancer in Medicare Part D

Por Caram, Megan E.V., Borza, Tudor, Min, Hye-Sung, Griggs, Jennifer J., Miller, David C., Hollenbeck, Brent K., Mukherjee, Bhramar, Skolarus, Ted A.
Publicado no J Oncol Pract (2017)

Potential Savings in Medicare Part D for Common Urological Conditions

Por Kirk, Peter S., Borza, Tudor, Dupree, James M., Wei, John T., Ellimoottil, Chad, Caram, Megan E. V., Burkhardt, Mary, Heidelbaugh, Joel J., Hollenbeck, Brent K., Skolarus, Ted A.
Publicado no Urol Pract (2018)

The implications of baseline bone health assessment at initiation of androgen deprivation therapy for prostate cancer

Por Kirk, Peter S., Borza, Tudor, Shahinian, Vahakn B., Caram, Megan E.V., Makarov, Danil V., Shelton, Jeremy B., Leppert, John T., Blake, Ryan M., Davis, Jennifer A., Hollenbeck, Brent K., Sales, Anne, Skolarus, Ted A.
Publicado no BJU Int (2017)

De-implementation of low value castration for men with prostate cancer: protocol for a theory-based, mixed methods approach to minimizing low value androgen deprivation therapy (De...

Por Skolarus, Ted A., Hawley, Sarah T., Wittmann, Daniela A., Forman, Jane, Metreger, Tabitha, Sparks, Jordan B., Zhu, Kevin, Caram, Megan E. V., Hollenbeck, Brent K., Makarov, Danil V., Leppert, John T., Shelton, Jeremy B., Shahinian, Vahakn, Srinivasaraghavan, Sriram, Sales, Anne E.
Publicado no Implement Sci (2018)